White Label, Private Label, or Custom Formula: Which Path Fits Your Supplement

There are three ways to put a supplement on the shelf, and the honest way to choose between them is to ask one question: where does the formula come from?

On a private label, the formula comes from the manufacturer: you brand a proven base. Bring your own formula and the recipe is already yours; the manufacturer scales it and runs it. Choose custom formulation and the formula gets built with you from the bench. “White label” and “private label” are two words for that first path. Everything else in the decision is trade-offs: speed, first commitment, how different your product is, and who owns what when it’s done.

Educational overview: not legal, regulatory, or medical advice. Requirements change and vary by jurisdiction and sales channel. Last reviewed July 2026.

Short answer. Three paths lead to a finished supplement, sorted by where the formula comes from. Private label puts your brand on a proven base the manufacturer owns: fastest, lowest first commitment, least differentiation. Bringing your own formula scales a recipe you already hold. Custom formulation builds one with you from the bench: the highest first commitment, but the formula is yours, not a base shared with other brands. (“White label” and “private label” are two names for that first path.)

Best for: Founders, clinics, creators, and existing brands deciding how to bring a product to market.

Key decision: Whether you need speed and a low first commitment, you already hold a formula, or the product itself has to be your differentiator.

Apollo path: Apollo Future Labs runs all three paths from one floor in Livermore, California. A manufacturing quote returns the path, the timeline, and the real minimum for your exact product.

White label, private label, custom: what the words actually mean

The vocabulary is the first place buyers get lost, because the industry uses it loosely. Here is the distinction that holds up.

White label is the most generic end of the spectrum. A manufacturer makes a finished product designed to be rebranded by many sellers; you add your label and sell it. Little or nothing about the product itself changes, and the same base can sit behind a dozen brand names. It’s the fastest and cheapest way to have a product, and the least yours.

Private label is the same basic move with more room. You still build on a base the manufacturer already makes, but with light customization (a flavor, a color, a bottle count, your own label and components), and your brand carries it. In practice, most manufacturers use “private label” to describe the whole stock-base-with-your-brand path, white label included.

The difference between the two words matters less than the one thing they share: on both, the formula isn’t yours. You own the brand you build on top of it. The base belongs to the manufacturer, who can sell it to the brand next to you on the shelf. So don’t shop on which word a vendor uses; shop on what you can actually change, and what you actually own.

That leaves two paths where the formula is yours. Custom formulation builds a new one with you from the bench. And the one most vendor pages skip (because they don’t offer it) is bringing a formula you already own and having it scaled and produced. Three paths, one sorting question: where does the formula come from?

Private label fast start: your brand on a proven base

This is the speed path. You choose a base the manufacturer already formulates and stocks, customize it lightly, put your brand on it, and go.

Because the formula already exists and the components are often on hand, very little stands between you and a first run. A private label fast start often reaches finished goods in about four to six weeks when the base and components are ready, the shortest route of the three. The first commitment is the lowest, too: there’s no bench work to pay for, and when the manufacturer stocks the bottle and closure, the fewest outside minimums sit in front of a small run.

What you trade for that speed is differentiation. A proven base is proven precisely because it isn’t unique; the manufacturer can sell the same one to anyone. Your product is only as distinct as your brand, your story, and your presentation. For a lot of buyers that’s exactly the right trade: the differentiation was always going to be the brand, and the product just has to be good and consistent. For others, where the product itself is the pitch, it isn’t enough.

Apollo runs this as a private label fast start: a stock-formulation review with light customization, your brand on the label, and the component minimums disclosed before you commit. It fits creators launching under their name, clinics that want a credible line without becoming manufacturers, and founders testing a market before they invest in something proprietary.

Bring your own formula: your recipe, our line

Some buyers already hold a formula. It came from a prior manufacturer, a formulator you hired, or your own kitchen and lab. You don’t need anyone to invent it; you need someone to make it, reliably, at the size you’re selling.

That’s its own path, and it’s the one vendor pages tend to leave out, because a shop selling its stock catalog has no reason to mention it. Here the manufacturer isn’t formulating; it’s validating and scaling. The work is a spec review (can this be made as written, are the actives compatible with the fill method and the container, does it hold up), then component sourcing and a pilot run before anything scales. It adds those cycles a private label doesn’t have, so it lands between the other two paths on speed and first commitment.

The important part is ownership, and it comes with a trap. Bringing your own formula only works if you actually own the formula, and many brands discover, when they go to move, that they don’t. A recipe developed under a private-label or a loosely written custom arrangement can belong to the manufacturer that made it, not the brand that sold it. Whether it’s yours turns entirely on what your agreement says, which is a question for your counsel, not for anyone’s marketing page. Confirm ownership before you plan a move. If you’re switching manufacturers, the transfer playbook covers how to protect supply while you do, and the formula-ownership check is the first thing on it.

Apollo runs this as bring your own formula: spec review, sourcing, pilot, production; your formula stays yours under our agreement. It fits established brands scaling or switching, and founders who’ve already validated a recipe and now need it made right.

Custom formulation: built from the bench

When the product itself has to be the differentiator, you build it. Custom formulation starts at the bench: the manufacturer’s R&D develops the formula to your target (the actives, the format, the taste and texture) and iterates with you on samples until it’s right.

That iteration is real work, and it’s where the time and the first cost go. Expect two to three bench rounds to dial in a formula, and more when flavor and masking are hard, as they are in a concentrated liquid or a functional shot. It’s the slowest path and the highest first commitment of the three: you’re paying for development, and you’re establishing the formula’s smallest practical batch and its custom components for the first time. In exchange you get the thing the other paths can’t give you: a formula that’s yours, not a base the manufacturer also sells to others.

The run size is smaller than the development cost suggests. A first production pilot often starts in the hundreds of units when compatible materials are on hand; you don’t have to commit to a warehouse of inventory to prove a custom product. The larger numbers you’ll see aren’t the line’s doing; they’re the components and the blend, which we’ll get to.

Apollo runs this as custom formulation and R&D: bench work, pilot runs sized to reality, and a testing plan, with ownership and costs disclosed upfront. It fits brands whose product is the pitch, and existing lines extending into something genuinely new. For liquids and shots specifically, what drives the cost of that development is its own subject; the liquid cost drivers piece breaks it down.

The decision table: speed, minimum, differentiation, IP, cost

Laid side by side, the trade-offs are easy to read. No path is best; each is best for something.

Two honest readings of that table. First: the fastest path and the most defensible path are opposite ends. Private label gets you to market soonest and differentiates least; custom differentiates most and asks the most upfront. That tension is the decision. Second: “bring your own formula” isn’t a compromise in the middle so much as a different situation entirely. It’s the right answer when the recipe already exists, and it barely competes with the other two because you’re not choosing where the formula comes from. You already know.

Who owns what: formula, artwork, and components

“Who owns it” deserves its own look, because it’s where the paths differ most and where buyers get surprised latest, often at the worst moment, when they try to leave.

Two points do the most work here. Your brand and your artwork are yours on every path; nobody keeps those. And the formula is the one thing that changes hands by path. On a private label you’re renting the recipe; that’s the trade you made for speed, and it’s a fair one as long as you know it going in. On custom, the formula is built for you and ownership is written into the deal. On bring-your-own, ownership rides entirely on the paperwork behind the formula you’re bringing, which is why “do you actually own it?” is the first question, and a question for your counsel. Apollo’s job is to make what you own clear and hand you the documentation; the legal ownership itself is yours and your counsel’s to settle.

How the minimum changes by path

If you’ve read Component Minimums vs. Finished Runs, the mechanism here will be familiar: a quoted “MOQ” is usually two numbers wearing one name (the finished units a line will run, and the component and blend minimums that outside suppliers set). The path you pick barely touches the first number and largely sets the second.

The finished-unit run stays small on all three paths. A line will fill a few hundred bottles whether the formula is stock, yours, or freshly developed; that’s what a pilot is. What the path changes is the second number:

• Private label clears the most minimums out of the way. The base is already formulated (often already run at scale, so no new blend floor is being established for you), and when the components are the manufacturer’s stock, no outside supplier minimum stands in front of a small run. Fewest minimums, lowest first commitment.
• Bring your own formula inherits whatever your formula and components demand. Your recipe has a smallest practical batch, and if you bring custom components (your own bottle, your own printed label), you take on those supplier minimums, commonly in the low thousands, and you own the overage.
• Custom formulation stacks both on purpose. You establish the formula’s smallest practical batch for the first time, and you choose custom components to match the positioning. More of your minimum lands in the supplier-set, buyer-owned column (not as waste, but as the reorder inventory a product that sells will use).

That overage is the part worth internalizing: a custom label printed in the low thousands against a run of a few hundred isn’t money lost, it’s your next several runs bought at a better per-piece price. The pricing and minimums section shows how each of these lines is quoted separately, so you see which minimum you’re actually committing to before you commit to anything.

Which path fits your situation

The paths map cleanly onto why a buyer is standing at the decision in the first place.

• First product or startup. Usually private label, to get to market fast and cheap and learn what sells, unless the product is the idea, in which case custom is the point and worth the cycles. It’s the fit Apollo builds for startups and first products.
• Clinic or practitioner. Private label is the usual fit. You want a credible line your patients trust and documentation you can stand behind, without becoming a manufacturer. Speed and a low first commitment matter more than a unique formula. Apollo runs the private-label path for clinics and practitioners.
• Creator or influencer. Private label fast start. Speed to launch and small first runs matter most; the differentiation is your audience and your brand, not the molecule. The one discipline: don’t overbuy components for a launch you’re still validating. It’s the path Apollo builds for creators and influencers.
• Existing brand switching manufacturers. Bring your own formula: you already own the product, once you’ve confirmed you do. This is the transfer case, and the work is validation and a clean cutover, not invention. Apollo runs this for existing brands.
• Existing brand extending the line. Either: private label to add a fast adjacent SKU, or custom when the extension needs to be genuinely differentiated. The question is the same one: does this product have to be unlike anything else, or just good and on-brand?

If you’re not sure which you are, that’s the conversation to have first. Describe the product and the run size you’re aiming for, and the people who run the lines will tell you which path actually fits.